VESIcare

VESIcare is a brand name of solifenacin, approved by the FDA in the following formulation(s):

VESICARE (solifenacin succinate - tablet; oral)

• 
  Manufacturer: ASTELLAS
  
  Approval date: November 19, 2004
  
  Strength(s): 10MG ^[RLD], 5MG
  

Has a generic version of VESIcare been approved?

No. There is currently no therapeutically equivalent version of VESIcare available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of VESIcare. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Quinuclidine derivatives and medicinal composition thereof
  Patent 6,017,927
  Issued: January 25, 2000
  Inventor(s): Takeuchi; Makoto & Naito; Ryo & Hayakawa; Masahiko & Okamoto; Yoshinori & Yonetoku; Yasuhiro & Ikeda; Ken & Isomura; Yasuo
  Assignee(s): Yamanouchi Pharmaceutical Co., Ltd.
  Quinuclidine derivatives represented by general following general formula (I), salts, N-oxides or quaternary ammonium salts thereof, and medicinal compositions containing the same. ##STR1## The compound has an antagonistic effect on muscarinic M.sub.3 receptors and is useful as a preventive or remedy for urologic diseases, respiratory diseases or digestive diseases.
  
  Patent expiration dates:
  
  
  • November 19, 2018
    
    ✓ 
    Drug substance
    ✓ 
    Drug product
  
  

See also...

• Vesicare Consumer Information (Drugs.com)
• VESIcare Consumer Information (Wolters Kluwer)
• VESIcare Consumer Information (Cerner Multum)
• Vesicare Advanced Consumer Information (Micromedex)
• Vesicare AHFS DI Monographs (ASHP)
• Solifenacin Consumer Information (Wolters Kluwer)
• Solifenacin Consumer Information (Cerner Multum)
• Solifenacin Advanced Consumer Information (Micromedex)
• Solifenacin Succinate AHFS DI Monographs (ASHP)